Together, these results showed that the expression of ASCL2 and ETV4 had negative correlation with T cell infiltration in the tumor microenvironment, indicating that overexpression of ASCL2 and ETV4 might inhibit the recruitment and activation of CD8+ T cells in MSS CRC patients. This evidence concerns the gene ASCL2 and colorectal carcinoma.